210 related articles for article (PubMed ID: 33248371)
1. Characterization of human papillomavirus (HPV) 16 E6 seropositive individuals without HPV-associated malignancies after 10 years of follow-up in the UK Biobank.
Brenner N; Mentzer AJ; Hill M; Almond R; Allen N; Pawlita M; Waterboer T
EBioMedicine; 2020 Dec; 62():103123. PubMed ID: 33248371
[TBL] [Abstract][Full Text] [Related]
2. Antibodies against high-risk human papillomavirus proteins as markers for noncervical HPV-related cancers in a Black South African population, according to HIV status.
Singini MG; Muchengeti M; Sitas F; Chen WC; Combes JD; Waterboer T; Clifford GM
Int J Cancer; 2024 Jul; 155(2):251-260. PubMed ID: 38577820
[TBL] [Abstract][Full Text] [Related]
3. Characterization of human papillomavirus antibodies in individuals with head and neck cancer.
Lang Kuhs KA; Pawlita M; Gibson SP; Schmitt NC; Trivedi S; Argiris A; Kreimer AR; Ferris RL; Waterboer T
Cancer Epidemiol; 2016 Jun; 42():46-52. PubMed ID: 27010729
[TBL] [Abstract][Full Text] [Related]
4. Human papillomavirus 16 E6 antibodies are sensitive for human papillomavirus-driven oropharyngeal cancer and are associated with recurrence.
Lang Kuhs KA; Kreimer AR; Trivedi S; Holzinger D; Pawlita M; Pfeiffer RM; Gibson SP; Schmitt NC; Hildesheim A; Waterboer T; Ferris RL
Cancer; 2017 Nov; 123(22):4382-4390. PubMed ID: 28950407
[TBL] [Abstract][Full Text] [Related]
5. Human papillomavirus infections and upper aero-digestive tract cancers: the ARCAGE study.
Anantharaman D; Gheit T; Waterboer T; Abedi-Ardekani B; Carreira C; McKay-Chopin S; Gaborieau V; Marron M; Lagiou P; Ahrens W; Holcátová I; Merletti F; Kjaerheim K; Talamini R; Simonato L; Castellsague X; Macfarlane TV; Biggs AM; Thakker N; Znaor A; Thomson P; Canova C; Conway DI; Healy CM; Tommasino M; Pawlita M; Brennan P
J Natl Cancer Inst; 2013 Apr; 105(8):536-45. PubMed ID: 23503618
[TBL] [Abstract][Full Text] [Related]
6. Sensitivity and specificity of antibodies against HPV16 E6 and other early proteins for the detection of HPV16-driven oropharyngeal squamous cell carcinoma.
Holzinger D; Wichmann G; Baboci L; Michel A; Höfler D; Wiesenfarth M; Schroeder L; Boscolo-Rizzo P; Herold-Mende C; Dyckhoff G; Boehm A; Del Mistro A; Bosch FX; Dietz A; Pawlita M; Waterboer T
Int J Cancer; 2017 Jun; 140(12):2748-2757. PubMed ID: 28316084
[TBL] [Abstract][Full Text] [Related]
7. Human Papillomavirus 16 E6 Antibodies in Individuals without Diagnosed Cancer: A Pooled Analysis.
Lang Kuhs KA; Anantharaman D; Waterboer T; Johansson M; Brennan P; Michel A; Willhauck-Fleckenstein M; Purdue MP; Holcátová I; Ahrens W; Lagiou P; Polesel J; Simonato L; Merletti F; Healy CM; Kjaerheim K; Conway DI; Macfarlane TV; Thomson P; Castellsagué X; Znaor A; Black A; Huang WY; Krogh V; Trichopoulou A; Bueno-de-Mesquita HB; Clavel-Chapelon F; Weiderpass E; Ekström J; Riboli E; Tjønneland A; Sánchez MJ; Travis RC; Hildesheim A; Pawlita M; Kreimer AR
Cancer Epidemiol Biomarkers Prev; 2015 Apr; 24(4):683-9. PubMed ID: 25623733
[TBL] [Abstract][Full Text] [Related]
8. Profiling of serum antibodies against human papillomavirus antigens in Korean women with cervical intraepithelial neoplasia and cervical cancer.
Jin Y; Choi JW; Kim HJ; Eddouzi J; Kim SC; Ju W; Kim YH; Kim HJ
Cancer Med; 2018 Nov; 7(11):5655-5664. PubMed ID: 30353680
[TBL] [Abstract][Full Text] [Related]
9. Kinetics of the Human Papillomavirus Type 16 E6 Antibody Response Prior to Oropharyngeal Cancer.
Kreimer AR; Johansson M; Yanik EL; Katki HA; Check DP; Lang Kuhs KA; Willhauck-Fleckenstein M; Holzinger D; Hildesheim A; Pfeiffer R; Williams C; Freedman ND; Huang WY; Purdue MP; Michel A; Pawlita M; Brennan P; Waterboer T
J Natl Cancer Inst; 2017 Aug; 109(8):. PubMed ID: 28376197
[TBL] [Abstract][Full Text] [Related]
10. Serum Antibodies to HPV16 Early Proteins Warrant Investigation as Potential Biomarkers for Risk Stratification and Recurrence of HPV-Associated Oropharyngeal Cancer.
Fakhry C; Qualliotine JR; Zhang Z; Agrawal N; Gaykalova DA; Bishop JA; Subramaniam RM; Koch WM; Chung CH; Eisele DW; Califano J; Viscidi RP
Cancer Prev Res (Phila); 2016 Feb; 9(2):135-41. PubMed ID: 26701665
[TBL] [Abstract][Full Text] [Related]
11. Development of DNA Vaccine Targeting E6 and E7 Proteins of Human Papillomavirus 16 (HPV16) and HPV18 for Immunotherapy in Combination with Recombinant Vaccinia Boost and PD-1 Antibody.
Peng S; Ferrall L; Gaillard S; Wang C; Chi WY; Huang CH; Roden RBS; Wu TC; Chang YN; Hung CF
mBio; 2021 Jan; 12(1):. PubMed ID: 33468698
[TBL] [Abstract][Full Text] [Related]
12. Timing, number, and type of sexual partners associated with risk of oropharyngeal cancer.
Drake VE; Fakhry C; Windon MJ; Stewart CM; Akst L; Hillel A; Chien W; Ha P; Miles B; Gourin CG; Mandal R; Mydlarz WK; Rooper L; Troy T; Yavvari S; Waterboer T; Brenner N; Eisele DW; D'Souza G
Cancer; 2021 Apr; 127(7):1029-1038. PubMed ID: 33426652
[TBL] [Abstract][Full Text] [Related]
13. A longitudinal study of human papillomavirus 16 L1, e6, and e7 seropositivity and oral human papillomavirus 16 infection.
Beachler DC; Viscidi R; Sugar EA; Minkoff H; Strickler HD; Cranston RD; Wiley DJ; Jacobson LP; Weber KM; Margolick JB; Reddy S; Gillison ML; D'Souza G
Sex Transm Dis; 2015 Feb; 42(2):93-7. PubMed ID: 25585068
[TBL] [Abstract][Full Text] [Related]
14. Absolute Risk of Oropharyngeal Cancer After an HPV16-E6 Serology Test and Potential Implications for Screening: Results From the Human Papillomavirus Cancer Cohort Consortium.
Robbins HA; Ferreiro-Iglesias A; Waterboer T; Brenner N; Nygard M; Bender N; Schroeder L; Hildesheim A; Pawlita M; D'Souza G; Visvanathan K; Langseth H; Schlecht NF; Tinker LF; Agalliu I; Wassertheil-Smoller S; Ness-Jensen E; Hveem K; Grioni S; Kaaks R; Sánchez MJ; Weiderpass E; Giles GG; Milne RL; Cai Q; Blot WJ; Zheng W; Weinstein SJ; Albanes D; Huang WY; Freedman ND; Kreimer AR; Johansson M; Brennan P
J Clin Oncol; 2022 Nov; 40(31):3613-3622. PubMed ID: 35700419
[TBL] [Abstract][Full Text] [Related]
15. Timing of HPV16-E6 antibody seroconversion before OPSCC: findings from the HPVC3 consortium.
Kreimer AR; Ferreiro-Iglesias A; Nygard M; Bender N; Schroeder L; Hildesheim A; Robbins HA; Pawlita M; Langseth H; Schlecht NF; Tinker LF; Agalliu I; Smoller SW; Ness-Jensen E; Hveem K; D'Souza G; Visvanathan K; May B; Ursin G; Weiderpass E; Giles GG; Milne RL; Cai Q; Blot WJ; Zheng W; Weinstein SJ; Albanes D; Brenner N; Hoffman-Bolton J; Kaaks R; Barricarte A; Tjønneland A; Sacerdote C; Trichopoulou A; Vermeulen RCH; Huang WY; Freedman ND; Brennan P; Waterboer T; Johansson M
Ann Oncol; 2019 Aug; 30(8):1335-1343. PubMed ID: 31185496
[TBL] [Abstract][Full Text] [Related]
16. Antibodies against high-risk human papillomavirus proteins as markers for invasive cervical cancer.
Combes JD; Pawlita M; Waterboer T; Hammouda D; Rajkumar T; Vanhems P; Snijders P; Herrero R; Franceschi S; Clifford G
Int J Cancer; 2014 Nov; 135(10):2453-61. PubMed ID: 24729277
[TBL] [Abstract][Full Text] [Related]
17. Human papillomavirus antibodies and future risk of anogenital cancer: a nested case-control study in the European prospective investigation into cancer and nutrition study.
Kreimer AR; Brennan P; Lang Kuhs KA; Waterboer T; Clifford G; Franceschi S; Michel A; Willhauck-Fleckenstein M; Riboli E; Castellsagué X; Hildesheim A; Fortner RT; Kaaks R; Palli D; Ljuslinder I; Panico S; Clavel-Chapelon F; Boutron-Ruault MC; Mesrine S; Trichopoulou A; Lagiou P; Trichopoulos D; Peeters PH; Cross AJ; Bueno-de-Mesquita HB; Vineis P; Larrañaga N; Pala V; Sánchez MJ; Navarro C; Barricarte A; Tumino R; Khaw KT; Wareham N; Boeing H; Steffen A; Travis RC; Quirós JR; Weiderpass E; Pawlita M; Johansson M
J Clin Oncol; 2015 Mar; 33(8):877-84. PubMed ID: 25667279
[TBL] [Abstract][Full Text] [Related]
18. Empirical sample-specific approaches to define HPV16 and HPV18 seropositivity in unvaccinated, young, sexually active women.
Ng K; Morais S; Wissing MD; Burchell AN; Tellier P-P; Coutlée F; Waterboer T; El-Zein M; Franco EL
Microbiol Spectr; 2024 Jun; 12(6):e0022924. PubMed ID: 38687066
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of human papillomavirus antibodies and risk of subsequent head and neck cancer.
Kreimer AR; Johansson M; Waterboer T; Kaaks R; Chang-Claude J; Drogen D; Tjønneland A; Overvad K; Quirós JR; González CA; Sánchez MJ; Larrañaga N; Navarro C; Barricarte A; Travis RC; Khaw KT; Wareham N; Trichopoulou A; Lagiou P; Trichopoulos D; Peeters PH; Panico S; Masala G; Grioni S; Tumino R; Vineis P; Bueno-de-Mesquita HB; Laurell G; Hallmans G; Manjer J; Ekström J; Skeie G; Lund E; Weiderpass E; Ferrari P; Byrnes G; Romieu I; Riboli E; Hildesheim A; Boeing H; Pawlita M; Brennan P
J Clin Oncol; 2013 Jul; 31(21):2708-15. PubMed ID: 23775966
[TBL] [Abstract][Full Text] [Related]
20. Human Papillomavirus (HPV) 16 E6 seropositivity is elevated in subjects with oral HPV16 infection.
Zhang Y; Waterboer T; Pawlita M; Sugar E; Minkoff H; Cranston RD; Wiley D; Burk R; Reddy S; Margolick J; Strickler H; Weber K; Gillison M; D'Souza G
Cancer Epidemiol; 2016 Aug; 43():30-4. PubMed ID: 27344614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
